Top Raleigh, NC Health Tech Companies With Best Stability & Growth (70)
.png)
GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is using the power of high-intensity sequencing, population-scale clinical studies, and state-of-the-art computer science and data science to enhance the scientific understanding of cancer biology, and to develop and commercialize pioneering products.
GRAIL's Top Stability & Growth Strengths
Strong Revenue Growth: Revenue is rising, with 2025 total revenue reaching roughly $147M and U.S. Galleri revenue about $136–137M. Early 2026 momentum continued as Galleri revenue increased to $39.8M on sharply higher test volumes (over 56,000 in Q1).
Strategic Partnerships: Distribution and access are expanding through integrations with Quest Diagnostics and Epic’s EHR that streamline ordering and broaden provider access. Additional channels such as Priority Health’s employer offering indicate widening availability.
Investor Backing & Capital Strength: Capital resources are sizable, including $823.1M in cash and securities as of March 31, 2026 and a $110M equity investment from Samsung entities. Management indicates a multiyear runway into 2030, supporting continued trials and commercialization.
Click Therapeutics, Inc., develops, validates, and commercializes software as prescription medical treatments for people with unmet medical needs. As a leading innovator of Digital Therapeutics™, Click delivers accessible, clinically proven, FDA-regulated prescription treatments to the smartphone in your hand. Click’s treatments are defined by a commitment to applying technical and scientific rigor and patient-centric design to the development process. This...
Click Therapeutics's Top Stability & Growth Strengths
Investor Backing & Capital Strength: Fresh capital arrived via a $50M April 2026 investment from Boehringer Ingelheim alongside an earlier Series C led by Dassault Systèmes/Medidata, extending resources for commercialization. The concurrent transfer of CT‑155 commercialization/marketing rights signals committed funding tied to revenue‑bearing activities.
Strategic Partnerships: Long‑running collaborations deepened with Boehringer Ingelheim (commercialization rights for CT‑155) and Otsuka (Rejoyn), while Dassault Systèmes/Medidata broadened a technology partnership to support scale‑up. A January 2026 partnership with Ultrahuman expands reach beyond traditional PDT channels.
Product Line Growth: Recent FDA authorizations for CT‑132 (episodic migraine) and Rejoyn (MDD) broaden the platform and advance the company toward launches. These milestones are highlighted as bolstering credibility for future products.
Optum, part of the UnitedHealth Group family of businesses, is a global organization that delivers care, aided by technology to help millions of people live healthier lives. The work you do with our team will directly improve health outcomes by connecting people with the care, pharmacy benefits, data and resources they need to feel their best. Here, you will find...
.jpg)
Optum's Top Stability & Growth Strengths
Profitability: Optum generated $4.0B in operating earnings in Q2 2026 with about 160 bps year‑over‑year margin expansion, and the parent raised its 2026 adjusted EPS outlook. Operating earnings also improved at Optum Insight and Optum Rx, signaling firming margin and earnings momentum.
Cost & Operational Efficiency: Operational improvements at Optum Insight and Optum Rx’s shift toward more transparent, fee‑based pricing supported better segment profitability. Margin expansion at the Optum level despite pockets of revenue softness indicates execution on efficiency initiatives.
Innovation-Driven Growth: Optum Insight introduced new AI‑enabled offerings, and Optum closed the Alegeus acquisition to expand consumer‑directed benefits capabilities. Model changes at Optum Rx toward transparent pricing further reflect product and business model innovation.
RHA Health Services is a provider of support services for individuals with intellectual and developmental disabilities, mental health needs, and substance use disorders. They offer a range of community-based, residential, and clinical programs to help individuals live independently and achieve their personal goals.
Hart & Hickman is a full-service environmental engineering and consulting firm that provides high-quality planning, permitting, regulatory and management services. We are serving clients throughout the Southeastern United States! Our well-trained engineers, geologists, scientists, and regulatory specialists provide unmatched ingenuity and results that are backed by expert senior review.
XpresSpa Group, Inc. is a health and wellness company that operates the world's largest airport spa business, offering services like massages, manicures, and facials to travelers.
Intelerad is a leader enterprise workflow and medical image archiving solutions for all types of healthcare organizations. Renowned for their innovative features and functionality, Intelerad solutions, such as InteleViewer™ and InteleOne® XE, increase productivity and streamline workflow by overcoming technical barriers in distributed and complex environments. Highly scalable, flexible and robust, Intelerad’s solutions offer high performance and industry leading customer...
Verily is an Alphabet company combining a data-driven, people-first approach to bring the promise of precision health to everyone, every day. We are focused on generating and applying evidence from a wide variety of sources to change the way people manage their health and the way healthcare is delivered - shifting the paradigm from “one size fits all” medicine to...
Verily's Top Stability & Growth Strengths
Investor Backing & Capital Strength: Recent $300M financing in March 2026, conversion to a C‑corp, and Alphabet remaining a significant minority investor indicate strong capital access to scale its AI‑native precision health platform. Earlier large rounds and ongoing backing provide resources for expansion while pursuing independence.
Product Line Growth: The company has expanded offerings with the AI‑native Pre platform (including opening Exchange and Workbench self‑serve/free tiers), the Verily Me app, and the Lightpath Metabolic program positioned for broad availability in 2026. These launches and migrations from Onduo signal a cohesive product strategy aimed at broader adoption.
Strategic Partnerships: Partnerships with NVIDIA, Samsung, UCHealth/CU Anschutz, and NIH “All of Us” via Vanderbilt, plus CMS ACCESS model participation, point to growing ecosystem traction. These collaborations expand research and care use cases and distribution channels.
Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it...
Veeva's Top Stability & Growth Strengths
Strong Revenue Growth: Revenue is rising at a double‑digit pace across recent quarters and the latest fiscal year, with momentum reflected in higher quarterly results and a raised full‑year outlook. Near‑term guidance also points to continued expansion through the remainder of the year.
Profitability: Profitability has expanded alongside growth, with operating income and earnings increasing meaningfully in the latest quarter. A subscription‑heavy mix and higher full‑year operating income guidance support margin durability.
Strong Market Position & Advantage: Position in life‑sciences CRM remains dominant, with a very large share of biopharma seats cited by management and many top‑20 pharmas live on next‑gen Vault CRM. Broad adoption across Development and Quality Clouds and continued big‑pharma commitments reinforce competitive advantage.
ProPharma is the premier Research Consulting Organization (RCO), delivering fully customizable consulting solutions to empower biotech, med device, and pharmaceutical organizations of all sizes to advance scientific breakthroughs confidently and introduce new therapies. With over 20 years of expertise in regulatory sciences, clinical research solutions, quality & compliance, pharmacovigilance, medical information, and R&D technology, ProPharma partners with clients across the...
Aledade is the largest network of independent primary care, enabling clinicians to deliver better patient outcomes and generate more savings revenue through value-based care. Aledade’s data, personal coaching, user-friendly workflows, health care policy expertise, strong payer relationships and integrated care solutions enable primary care organizations to succeed financially by keeping people healthy. Together with more than 1,900 practices and community...
Aledade's Top Stability & Growth Strengths
Strong Market Position & Advantage: Aledade is positioned as a category leader in value-based care enablement for independent primary care, supported by its large national network and repeated references to outsized influence in Medicare ACO participation and savings outcomes.
Investor Backing & Capital Strength: The company is described as having substantial funding and financing capacity, including major equity rounds and a large senior secured credit facility intended to support scaling and working-capital needs.
Market Expansion: The organization is described as expanding rapidly in geographic footprint and partner counts, with continued additions of new primary care organizations across dozens of states and growth in covered patient lives.
At Mallinckrodt, we use strategic vision and employee-driven momentum to pursue a powerful mission: Listening for needs and delivering solutions. As a leader in specialty pharmaceuticals, we develop, manufacture, market and distribute innovative treatments for underserved patient populations within neurology, rheumatology, hepatology, nephrology, pulmonology, ophthalmology, and oncology; immunotherapy and neonatal respiratory critical care therapies; analgesics; cultured skin substitutes and gastrointestinal...
Sunnybrook Rehabilitation Center is a rehabilitation facility located in Raleigh that provides a caring environment to meet rehabilitation and nursing needs, aiming to help patients return to their prior level of function.
Founded in 2013 by Military Veterans, Unite Us is the nation’s premier technology provider for integrating health and community-based care. Our advanced product suite is used to proactively coordinate services using data-driven insights, streamline referral and case management, and facilitate eligibility assessments and reimbursements across government, healthcare, health plans, and community organizations. The first of its kind, our closed-loop referral...
Unite Us's Top Stability & Growth Strengths
Strong Market Position & Advantage: The company is repeatedly characterized as the nation’s leading or premier platform for integrating health and social care, powering the largest outcomes-driven network with broad statewide programs and measurable impact. Recognition such as inclusion on TIME’s 2025 World’s Top HealthTech Companies and large-scale deployments reinforce a durable competitive position.
Strategic Partnerships: Relationships span major health systems and insurers and statewide government initiatives, alongside backing from prominent investors. State Medicaid initiatives and Social Care Networks selecting the platform indicate embedded ties across payers, providers, and community organizations.
Innovation-Driven Growth: Acquisitions like Carrot Health and NowPow expanded analytics and referral capabilities, while product enhancements added predictive analytics, closed-loop referrals, and integrated eligibility and payments. Ongoing platform updates and AI-driven features are intended to improve ROI and accelerate adoption.
In just over a decade, Sono Bello® has grown into an industry leader with 100+ locations spanning across the United States. Our growth is made possible by an amazing team of board-certified surgeons that are now over 185 strong, as well as our entire team of dedicated Sono Bello® employees. With our eyes to the future, we look forward to opening...
By the year 2050, the number of people in the U.S. age 65 and over will swell to almost 90 million, about twice the current population. For over 20 years, TheKey has helped clients achieve long-term aging at home with comprehensive, concierge-based care. As the leading private pay home care provider in the nation, TheKey is continuing to address this...
Intuitive (Nasdaq: ISRG), headquartered in Sunnyvale, Calif., is a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery. At Intuitive, we believe that minimally invasive care is life-enhancing care. Through ingenuity and intelligent technology, we expand the potential of physicians to heal without constraints. Intuitive brings more than two decades of leadership in robotic-assisted surgical technology and...
Intuitive's Top Stability & Growth Strengths
Strong Market Position & Advantage: Dominant leadership is reinforced by being a pioneer in robotic-assisted surgery and maintaining a large, entrenched installed base that drives broad adoption. Competitive moats are further supported by surgeon training and ecosystem stickiness tied to hospital investments and workflow standardization.
Strong Revenue Growth: Revenue is described as growing strongly year over year, alongside sustained multi-year growth and forward projections that indicate continued expansion. Procedure volumes are also rising at a double-digit pace, supporting ongoing demand for the core platform.
Diversified Revenue Streams: A large share of revenue is characterized as recurring, driven by instruments, accessories, services, and usage tied to procedure volume rather than one-time system sales. This mix supports a steadier business profile as the installed base expands.
Luna is a leading in-home, tech-enabled physical therapy platform that provides 1:1 personalized care. By shifting treatment from the clinic to the home, the company improves accessibility, convenience, and patient outcomes. Luna leverages proprietary technology like Auto-Charting® to streamline documentation for therapists, allowing them to focus on patient care. The company partners with major health systems and is covered by...
The National MS Society is a non-profit organization dedicated to curing multiple sclerosis while empowering people affected by the disease to live their best lives through research, education, and support.
Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals, who work across more than 110 countries, with a deep understanding of patient and physician behaviors and market dynamics. Together...
Syneos Health's Top Stability & Growth Strengths
Strong Market Position & Advantage: Company materials and third‑party recognition portray a fully integrated CRO/CCO with leadership status, including widespread involvement in recent FDA/EMA novel therapies and recognition as a leading pharmacovigilance provider.
Strategic Partnerships: Recent collaborations with Microsoft and KX are positioned to enable AI‑driven efficiencies across clinical and commercial operations, with reported improvements in cycle times supporting operational scalability.
Investor Backing & Capital Strength: The 2025 take‑private by investment groups (including Elliott and Veritas) provides financial sponsorship to pursue tech‑enabled growth and operational repositioning.
